Shares of Aphria Inc (NYSE:APHA) were down 5.3% during trading on Friday . The stock traded as low as $9.45 and last traded at $9.53. Approximately 4,286,521 shares traded hands during trading, a decline of 43% from the average daily volume of 7,458,813 shares. The stock had previously closed at $10.06.
Several analysts recently commented on APHA shares. Seaport Global Securities started coverage on shares of Aphria in a report on Thursday, February 21st. They set a “buy” rating and a $18.00 target price for the company. Cormark set a $15.00 target price on shares of Aphria and gave the company a “buy” rating in a research report on Saturday, February 2nd. Canaccord Genuity reiterated a “buy” rating on shares of Aphria in a research report on Wednesday, December 5th. Eight Capital cut shares of Aphria to a “hold” rating and set a $7.00 price objective for the company. in a research report on Thursday, December 13th. Finally, CIBC assumed coverage on shares of Aphria in a report on Friday, January 18th. They set a “neutral” rating on the stock. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Aphria presently has a consensus rating of “Buy” and a consensus target price of $13.33.
The firm has a market cap of $2.43 billion, a P/E ratio of 68.11 and a beta of 4.20.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Norges Bank bought a new position in shares of Aphria in the fourth quarter worth approximately $10,301,000. Actinver Wealth Management Inc. bought a new stake in shares of Aphria during the 4th quarter valued at $250,000. Financial Advocates Investment Management bought a new stake in shares of Aphria during the 4th quarter valued at $89,000. Cetera Advisor Networks LLC bought a new stake in shares of Aphria during the 4th quarter valued at $177,000. Finally, Legal & General Group Plc bought a new stake in shares of Aphria during the 4th quarter valued at $297,000. 9.67% of the stock is currently owned by institutional investors and hedge funds.
About Aphria (NYSE:APHA)
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: Stock Symbol
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.